BHVN | Biohaven Pharmaceutical Holding Company Ltd. Stock Overview

(Stock Exchange: NYSE)

Day's Range	34.46 - 36.61
52 Week Range	26.80 - 62.21
Beta	1.98
Implied Volatility	77.11%
IV Rank	22.77%
Day's Volume	1,105,162
Average Volume	1,045,779
Shares Outstanding	101,122,246
Market Cap	3,666,692,640
Sector	Healthcare
Industry	Biotechnology
IPO Date	2022-09-23

Valuation
Profitability
Growth
Health
P/E Ratio	-3.87
Forward P/E Ratio	N/A
EPS	-9.37
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	239
Country	USA
Website	BHVN

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

BHVN's peers: IMNM, INBX, AGE, ICVX, DAWN, TERN, XFOR, INZY, MREO, APLS, BPMC, CERE, MRTX, AMLX, KYMR, RVMD, CCCC, AGIO, NRIX, TLSA

*Chart delayed

Analyzing fundamentals for BHVN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see BHVN Fundamentals page.

Watching at BHVN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BHVN Technicals page.